OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
2.653
-0.017 (-0.65%)
Aug 14, 2025, 1:39 PM - Market open

OKYO Pharma Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2016 - 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
Net Income
-4.71-16.83-13.27-5.43-3.35
Upgrade
Depreciation & Amortization
00000.01
Upgrade
Loss (Gain) From Sale of Assets
----0-0
Upgrade
Stock-Based Compensation
1.411.131.321.80.63
Upgrade
Other Operating Activities
-0.153.530.31-0.810.05
Upgrade
Change in Accounts Receivable
---0.03-0
Upgrade
Change in Accounts Payable
1.722.233.78-0.250.84
Upgrade
Change in Other Net Operating Assets
-0.090.440.17-0.80.21
Upgrade
Operating Cash Flow
-1.81-9.49-7.7-5.47-1.6
Upgrade
Capital Expenditures
-0--0.01-0-0.01
Upgrade
Other Investing Activities
-----0.01
Upgrade
Investing Cash Flow
-0--0.01-0-0.02
Upgrade
Short-Term Debt Issued
--2--
Upgrade
Long-Term Debt Issued
0.95---7.59
Upgrade
Total Debt Issued
0.95-2-7.59
Upgrade
Long-Term Debt Repaid
-----0.01
Upgrade
Net Debt Issued (Repaid)
0.95-2-7.58
Upgrade
Issuance of Common Stock
1.716.217.322.150.25
Upgrade
Financing Cash Flow
2.666.219.322.157.83
Upgrade
Foreign Exchange Rate Adjustments
-0.110.06-0.28-0.870.45
Upgrade
Miscellaneous Cash Flow Adjustments
----0
Upgrade
Net Cash Flow
0.73-3.221.34-4.196.65
Upgrade
Free Cash Flow
-1.81-9.49-7.7-5.47-1.61
Upgrade
Free Cash Flow Per Share
-0.05-0.32-0.35-0.36-0.15
Upgrade
Cash Income Tax Paid
-2--0.2--0.08
Upgrade
Levered Free Cash Flow
-2.72-3.09-2.77-3.9-0.31
Upgrade
Unlevered Free Cash Flow
-2.18-2.44-2.71-3.9-0.31
Upgrade
Change in Working Capital
1.632.673.95-1.021.04
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q